CANYON CAPITAL ADVISORS LLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 17 filers reported holding ACORDA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CANYON CAPITAL ADVISORS LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$28,747,000
-0.7%
36,500,000
+7.4%
0.62%
+5.6%
Q2 2019$28,947,000
+5.2%
34,000,000
+9.7%
0.59%
-11.3%
Q1 2019$27,517,000
+15.5%
31,000,000
+7.7%
0.66%
+18.0%
Q4 2018$23,830,000
-2.5%
28,775,0000.0%0.56%
+69.3%
Q3 2018$24,434,000
-12.1%
28,775,0000.0%0.33%
+7.4%
Q2 2018$27,809,000
+6.3%
28,775,0000.0%0.31%
+17.0%
Q1 2018$26,153,000
+7.3%
28,775,0000.0%0.26%
-24.8%
Q4 2017$24,369,000
-6.9%
28,775,000
-0.8%
0.35%
-10.2%
Q3 2017$26,173,000
+5.2%
29,000,0000.0%0.39%
-4.9%
Q2 2017$24,886,000
+39.6%
29,000,000
+38.3%
0.41%
-6.8%
Q1 2017$17,829,00020,975,0000.44%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 8,750,000$6,650,0003.76%
Mohican Financial Management, LLC 3,000,000$2,280,0002.84%
BASSO CAPITAL MANAGEMENT, L.P. 11,200,000$8,512,0001.28%
ANGELO GORDON & CO., L.P. 22,500,000$17,100,0001.26%
Context Capital Management, LLC 1,500,000$1,140,0001.25%
Opera Trading Capital 4,500,000$3,400,0001.02%
Jabre Capital Partners S.A. 6,650,000$5,037,0000.58%
Castle Creek Arbitrage, LLC 6,000,000$4,576,0000.44%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 28,000,000$21,345,000,0000.41%
Man Investments (CH) AG 700,000$536,0000.31%
View complete list of ACORDA THERAPEUTICS INC shareholders